Mercados españoles cerrados en 7 hrs 6 min

Endonovo Therapeutics, Inc. (ENDV)

OTC Markets OTCPK - OTC Markets OTCPK Precio demorado. Divisa en USD
Añadir a la lista de favoritos
0,0015+0,0001 (+7,14%)
Al cierre: 03:37PM EDT

Endonovo Therapeutics, Inc.

6320 Canoga Avenue
15th Floor
Woodland Hills, CA 91367
United States
800 489 4774
https://www.endonovo.com

Sector(es)Healthcare
SectorBiotechnology
Empleados a tiempo completo

Descripción

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Gobierno corporativo

El ISS Governance QualityScore de Endonovo Therapeutics, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.